ITC To Investigate Sanofi Over Insulin Delivery Patent

Law360, New York (June 8, 2006, 12:00 AM EDT) -- The International Trade Commission plans to investigate whether drug maker Sanofi-Aventis violated patent laws in what has turned into a bittersweet struggle over an insulin delivery system patent between the French company and Danish drug maker Novo Nordisk A/S.

The ITC said Wednesday it will hold an initial hearing to rule on whether Sanofi breached patent regulations, a decision that could block the company from importing its handheld OptiClik pen system for Type 1 and Type 2 diabetes into the United States.

Novo Nordisk launched a...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.